Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03307785
Title Study of Niraparib or Carboplatin-Paclitaxel in Combination With TSR-042
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Tesaro, Inc.

Advanced Solid Tumor


Carboplatin + Dostarlimab-gxly + Paclitaxel

Dostarlimab-gxly + Niraparib

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.